Patients with advanced UC , measurable disease , and adequate organ function were randomized @:@ to cisplatin ( @ mg/m ( @ ) ) on day @ plus gemcitabine ( @ mg/m ( @ ) ) on days @ , @ , and @ ( arm A ) or GC plus CTX ( @ mg/m ( @ ) ) on days @ and @ ( arm B ) .